Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
7.44M
-
Shares change
-
-461K
-
Total reported value, excl. options
-
$34.7M
-
Value change
-
-$2.55M
-
Number of buys
-
13
-
Number of sells
-
-12
-
Price
-
$4.65
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2017
30 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2017.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.44M shares
of 59.6M outstanding shares and own 12.48% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (2.89M shares), FMR LLC (1.65M shares), SPHERA FUNDS MANAGEMENT LTD. (876K shares), 683 Capital Management, LLC (525K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (475K shares), VANGUARD GROUP INC (305K shares), Knoll Capital Management, LP (124K shares), Hikari Power Ltd (108K shares), MILLENNIUM MANAGEMENT LLC (101K shares), and SABBY MANAGEMENT, LLC (97.7K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.